CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.

<h4>Objective</h4>The aim of this study was to report the basic cerebrospinal fluid (CSF) profile in patients with primary progressive multiple sclerosis (PPMS).<h4>Methods</h4>The results of CSF analysis from 254 patients with PPMS were collected at four university hospitals...

Full description

Bibliographic Details
Main Authors:	Ahmed Abdelhak, Tilman Hottenrott, Christoph Mayer, Gudrun Hintereder, Uwe K Zettl, Oliver Stich, Hayrettin Tumani
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182647&type=printable

Similar Items

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
by: Ahmed Abdelhak, et al.
Published: (2019-03-01)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
by: Ahmed Abdelhak, et al.
Published: (2017-05-01)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
by: Tilman Robinson, et al.
Published: (2020-11-01)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
by: Hela-Felicitas Petereit, et al.
Published: (2021-06-01)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
by: Makbule Senel, et al.
Published: (2019-03-01)

Cerebrospinal fluid biomarkers in multiple sclerosis
by: Hayrettin Tumani, et al.
Published: (2009-08-01)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
by: André Huss, et al.
Published: (2020-07-01)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
by: Veronika Klose, et al.
Published: (2023-05-01)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
by: Ahmed Abdelhak, et al.
Published: (2020-06-01)

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
by: Ahmed Abdelhak, et al.
Published: (2024-02-01)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
by: André Huss, et al.
Published: (2020-08-01)

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis
by: Tilman Hottenrott, et al.
Published: (2018-01-01)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
by: Matthias Grothe, et al.
Published: (2023-09-01)

The TRACK-MS Test Battery: A Very Brief Tool to Track Multiple Sclerosis-Related Cognitive Impairment
by: Daniela Taranu, et al.
Published: (2022-11-01)

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
by: Petra Steinacker, et al.
Published: (2011-01-01)

Neurochemical Biomarkers in patients with COVID-19
by: Hayrettin Tumani
Published: (2023-04-01)

The pathophysiology of motor fatigue and fatigability in multiple sclerosis
by: Robert Patejdl, et al.
Published: (2022-07-01)

Serum GFAP as a biomarker for disease severity in multiple sclerosis
by: A. Abdelhak, et al.
Published: (2018-10-01)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
by: Benjamin Vlad, et al.
Published: (2023-03-01)

Multiple Sclerosis and <i>Clostridium perfringens</i> Epsilon Toxin: Is There a Relationship?
by: André Huss, et al.
Published: (2024-06-01)

Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study
by: Alexander Winkelmann, et al.
Published: (2023-09-01)

Challenges in monitoring the quality of care in multiple sclerosis
by: Uwe Klaus Zettl, et al.
Published: (2024-07-01)

A study of CSF idiotypes in multiple sclerosis.
by: Ebers, G
Published: (1982)

CSF chitinase proteins in amyotrophic lateral sclerosis
by: Thompson, A, et al.
Published: (2019)

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
by: William T. Hu, et al.
Published: (2019-03-01)

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
by: Claudia D. Wurster, et al.
Published: (2019-11-01)

CXCL13 CSF level inversely correlates with duration of disease in primary progressive multiple sclerosis
by: Jacek Losy, et al.
Published: (2016-12-01)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
by: Benjamin Vlad, et al.
Published: (2023-09-01)

Headaches in multiple sclerosis patients might imply an inflammatorial process.
by: Jan Möhrke, et al.
Published: (2013-01-01)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
by: Niklas Frahm, et al.
Published: (2019-05-01)

Vaccination in Multiple Sclerosis: Friend or Foe?
by: Tobias Zrzavy, et al.
Published: (2019-08-01)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
by: Huang, J, et al.
Published: (2020)

Small peptide CSF fingerprint of amyotrophic lateral sclerosis.
by: Rea Lumi, et al.
Published: (2024-01-01)

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
by: Niklas Frahm, et al.
Published: (2019-01-01)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
by: Kai He, et al.
Published: (2022-07-01)

Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
by: Makbule Senel, et al.
Published: (2014-01-01)

Video basics 6 /
by: 358806 Zettl, Herbert
Published: (2010)

Video basics 5 /
by: 358806 Zettl, Herbert
Published: (2007)

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
by: Krizia Sanna, et al.
Published: (2024-06-01)

Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
by: Michael Hecker, et al.
Published: (2023-12-01)